Defence Therapeutics (TSE:DTC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Defence Therapeutics has appointed radiopharmaceutical expert Dr. Svetlana Selivanova to its board, enhancing its strategic focus on developing targeted therapies. This move is expected to strengthen the company’s radiopharmaceutical programs and accelerate progress using their proprietary Accum technology.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.
